[Treatment of hepatic and intra-abdominal hydatidosis with mebendazole: prospective comparison of the cyclic and the continuous regimen].
OBJECTIVE
To communicate the results of two different schedules (cyclic and continuous) of mebendazole therapy for hepatic and intraabdominal hydatid disease.


METHODS
Prospective and randomized.


METHODS
26 cases of abdominal hydatid disease.


RESULTS
No significant differences were registered between both groups.


CONCLUSIONS
Cyclic mebendazole therapy does not improve the results of continuous treatment in abdominal hydatid disease.
Gil Grande
L A
LA
Servicio de Gastroenterología, Hospital Ramón y Cajal, Madrid.
Sánchez Ruano
J J
JJ
López San Román
A
A
García-Hoz
F
F
Barcena
R
R
Salinas
F
F
D000005:Abdomen; D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D004334:Drug Administration Schedule; D004443:Echinococcosis / Q000188:drug therapy*; D004444:Echinococcosis, Hepatic; D005260:Female; D006801:Humans; D008297:Male; D008463:Mebendazole / Q000008:administration & dosage* / Q000627:therapeutic use; D008875:Middle Aged; D011446:Prospective Studies
D008463:Mebendazole
Tratamiento de la hidatidosis hepática e intraabdominal con mebendazol: comparación prospectiva de las pautas cíclica y contínua.